Virginie Prendki Selected Research

Virginie Prendki Research Topics

Disease

12	Pneumonia (Pneumonitis) 09/2022 - 09/2017
6	Infections 01/2022 - 03/2011
4	COVID-19 02/2022 - 11/2020
2	Abscess 01/2020 - 01/2013
2	Malaria 09/2016 - 01/2014
1	Inflammation (Inflammations) 09/2022
1	Frailty 06/2022
1	Critical Illness (Critically Ill) 02/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Dementia (Dementias) 12/2021
1	Periodontitis 04/2021
1	Cognitive Dysfunction 12/2020
1	Respiratory Sounds (Crackle) 11/2020
1	Heart Failure 11/2020
1	Peripheral Arterial Disease 11/2020
1	Headache (Headaches) 11/2020
1	Necrosis 01/2020
1	Muscle Weakness 01/2020
1	Deglutition Disorders (Dysphagia) 01/2020
1	Muscular Diseases (Myopathy) 01/2020
1	Bacteremia 01/2020
1	Hypercholesterolemia 01/2020
1	Rhabdomyolysis 01/2020
1	Cough 04/2019
1	Autoimmune Diseases (Autoimmune Disease) 10/2018
1	Pleural Effusion (Pleural Effusions) 10/2018
1	Sepsis (Septicemia) 11/2016
1	Hypoxia (Hypoxemia) 09/2016
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2016
1	Latent Tuberculosis 05/2015
1	Lymphopenia (Lymphocytopenia) 11/2014
1	Acute malaria 01/2014
1	Colitis 11/2013
1	Diarrhea 11/2013
1	Hypophosphatemia 05/2011
1	Pain (Aches) 05/2011
1	Neurofibromatoses (Neurofibromatosis) 05/2011
1	Osteomalacia 05/2011
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 05/2011
1	Hyperplasia 03/2011
1	Amyloidosis 01/2011
1	Joint Diseases (Joint Disease) 01/2011
1	Gardner Syndrome 11/2009

Drug/Important Bio-Agent (IBA)

10	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 11/2013
5	C-Reactive ProteinIBA 09/2022 - 04/2019
3	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2020
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 09/2022 - 01/2020
2	NeopterinIBA 09/2022 - 01/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2022 - 12/2020
2	Ritonavir (Norvir)FDA Link 02/2022 - 12/2020
2	Lopinavir FDA Link 02/2022 - 12/2020
2	Antinuclear AntibodiesIBA 10/2018 - 01/2014
2	AutoantibodiesIBA 10/2018 - 01/2014
2	Biological ProductsIBA 11/2016 - 11/2014
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2022
1	Phosphorylcholine (Phosphocholine)IBA 09/2022
1	Peroxidase (Myeloperoxidase)IBA 09/2022
1	InterleukinsIBA 09/2022
1	Immunoglobulin M (IgM)IBA 09/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2022
1	tocilizumab (atlizumab)FDA Link 02/2022
1	remdesivirIBA 02/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2022
1	SteroidsIBA 02/2022
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2022
1	Colistin (Coly-Mycin)FDA Link 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Interleukin-8 (Interleukin 8)IBA 12/2021
1	pro-brain natriuretic peptide (1-76)IBA 12/2021
1	Oxygen (Dioxygen)IBA 11/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	ProcalcitoninIBA 01/2020
1	Urea (Carbamide)FDA LinkGeneric 04/2019
1	hemoglobin AAIBA 09/2016
1	Vincristine (Oncovin)FDA LinkGeneric 03/2016
1	Inosine Triphosphate (ITP)IBA 03/2016
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2014
1	AutoantigensIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Vancomycin FDA LinkGeneric 11/2013
1	Metronidazole (Metric)FDA LinkGeneric 11/2013
1	Immunologic Factors (Immunomodulators)IBA 01/2013
1	Phosphates (Orthophosphate)IBA 05/2011
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 05/2011
1	Tenofovir (Viread)FDA Link 05/2011
1	PerforinIBA 03/2011
1	Amyloid (Amyloid Fibrils)IBA 01/2011
1	DiamondIBA 11/2009

Therapy/Procedure

11	Therapeutics 02/2022 - 05/2011
2	Oral Hygiene (Dental Hygiene) 04/2021 - 11/2018
2	Drug Therapy (Chemotherapy) 12/2020 - 05/2015
1	Critical Care (Surgical Intensive Care) 06/2022
1	Institutionalization (Institutionalized Persons) 12/2020
1	Length of Stay 12/2020
1	Contraindications 12/2020
1	Investigational Therapies (Experimental Therapy) 12/2020
1	Duration of Therapy 01/2020
1	Prostheses and Implants (Prosthesis) 12/2014